BARCELONA—Researchers have documented a small but significant stage migration in metastatic bladder cancer between 1988 and 2006.

The FDA has approved Cysview (hexaminolevulinate HCl), an optical imaging agent indicated for use in the cystoscopic detection of non-muscle-invasive papillary bladder cancer in patients suspected or known to have lesions on the basis of prior cystoscopy.

Even 30 or more years after their last exposure to aromatic amines, which are known bladder carcinogens, individuals have an excess risk of bladder cancer, a study found.

SAN FRANCISCO—Prostate biopsies performed after treatment with 5-alpha reductase inhibitors increase the rate of prostate cancer detection, researchers reported at the American Urological Association annual meeting.

SAN FRANCISCO—Finasteride and dutasteride are similarly effective for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia in properly selected patients, but dutasteride is associated with significantly greater sexual side effects and breast complications, researchers reported.

They cause fewer UTIs than indwelling catheters in men at high risk during anesthesia and surgery.

TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting of the International Continence Society and the International Urogynecological Association.

SAN FRANCISCO—New research implicates erectile dysfunction (ED) as an independent risk factor for high-risk coronary artery calcification.

Erectile dysfunction (ED) is a strong predictor of all-cause mortality and the composite of cardiovascular death, heart attack, stroke, and heart failure in men with cardiovascular disease (CVD), according to the results of a worldwide study of 1,519 men with ED and CVD.

Erectile dysfunction (ED) is a strong predictor of all-cause mortality and the composite of cardiovascular death, heart attack, stroke, and heart failure in men with cardiovascular disease (CVD), according to the results of a worldwide study of 1,519 men with ED and CVD.

For men who have had external beam radiotherapy (EBRT) for prostate cancer, the greatest decline in sexual function is in the first 24 months post-treatment, with no significant changes thereafter, according to a report in the International Journal of Radiation Oncology, Biology, Physics (2010;76:31-35).

Percutaneous cryoablation of larger renal masses can be performed with high technical success and low complication rates, according to researchers.

Warm ischemia during partial nephrectomy (PN) on a solitary kidney is associated with an increased risk of acute renal failure (ARF) and CKD, according to researchers.

Cook Medical, of Bloomington, Ind., has introduced BIGopsy Backloading Biopsy Forceps, a device that has a 4 mm3 biopsy cup to obtain large renal or ureteral tissue specimens for cancer diagnosis.

Individuals who form kidney stones are at increased risk for myocardial infarction (MI) independent of CKD and other risk factors, according to researchers.

Socioeconomic status (SES) influences dietary habits, and this may strongly affect stone formation and recurrence, according to researchers at Emory University in Atlanta.

Doxazosin significantly improves expulsion of distal ureteral stones, according to researchers in Pakistan.

Mission Pharmacal Company has introduced the Urocit-K 15 mEq (potassium citrate) extended-release tablet.

During a five-year period, stones were diagnosed in 4.9% of obese and 2.6% of non-obese subjects.

TORONTO—An analysis of gene-expression patterns in women with overactive bladder (OAB) may point the way to possible new biomarkers for the condition.

SAN FRANCISCO—Increasing levels of C-reactive protein (CRP) are associated with increasing odds of overactive bladder (OAB), according to a population-based study of men and women.

Percutaneous tibial nerve stimulation (PTNS) is safe and effective for treating overactive bladder (OAB) symptoms, a recent study shows.

The associated cost is a potential reason for undertreatment.

Only 24.4% of patients aged 45 years and older take drugs for the condition, according to researchers.

SAN FRANCISCO—Pivotal clinical trials of a novel treatment for premature ejaculation (PE) have yielded promising results, a researcher announced here at a press conference during the American Urological Association annual meeting.

Men suffering from premature ejaculation had a sixfold increase in intravaginal ejaculatory time.

Dapoxetine shows efficacy in the treatment of premature ejaculation (PE), according to a new study that researchers say is the most comprehensive to date examining a pharmacologic treatment for PE.

ORLANDO—For the first time, clinicians have an evidence-based definition of premature ejaculation (PE).

A panel of sexual health authorities has developed what they say is the first evidence-based definition of premature ejaculation (PE).

TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting of the International Continence Society and the International Urogynecological Association.

Twenty years ago, a man I revered calmly shared the news that he had just been diagnosed with metastatic prostate cancer. Frank A. Oski, MD, was chair of pediatrics at Johns Hopkins, a beloved, iconic, and iconoclastic figure to thousands of students, faculty, and practicing clinicians throughout the realm of children's health care, a brilliant mind who loved nothing better than tweaking the pretensions of the medically effete.

Active surveillance may be a suitable option for many men with low-risk prostate cancer (PCa), Swedish researchers concluded.

SAN FRANCISCO—Initiating statin therapy after radical prostatectomy (RP) may decrease the risk of biochemical recurrence of prostate cancer, new data suggest.

Deaths from prostate cancer (PCa) fell by almost half after 14 years of biennial screening, according to data from a Swedish study.

Deaths from prostate cancer (PCa) fell by almost half after 14 years of biennial screening, according to data from a Swedish study.

SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.

SAN FRANCISCO—PSA doubling time (PSADT) is the most important predictor of 15-year overall survival among men who experience biochemical recurrence after radical prostatectomy for prostate cancer, according to a study.

Aspirin use is associated with lower PSA levels in men who have never smoked, data suggest.

SAN FRANCISCO—The prostate cancer gene 3 (PCA3) molecular urine test is more accurate than the PSA test in predicting outcomes of repeat biopsies, new findings confirm.

Most men who undergo radiation therapy (RT) for prostate cancer will develop anejaculation, a new study shows.

CHICAGO—Testicular cancer survivors treated with chemotherapy and radiotherapy are at increased risk for cardiovascular disease (CVD), researchers reported at the American Society of Clinical Oncology annual meeting. These patients also are at higher risk for hypertension and diabetes.

Recurrence rates after percutaneous embolization are similar to those of surgery, researcher says.

BARCELONA—Alfuzosin 10 mg once-daily (OD) improves ejaculatory dysfunction in sexually active men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH), according to new findings presented here at the 25th Anniversary European Association of Urology Congress.

Infertile men may be at increased risk for high-grade prostate cancer (PCa), according to researchers at the University of California-San Francisco.

TORONTO—A modified inside-out transobturator (TVT-O) procedure is safe and effective for treating stress urinary incontinence (SUI) in women, according to data presented at the joint annual meeting of the International Continence Society and the International Urogynecological Association.

TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting of the International Continence Society and the International Urogynecological Association.

TORONTO—An analysis of gene-expression patterns in women with overactive bladder (OAB) may point the way to possible new biomarkers for the condition.

TORONTO—Caesarean deliveries significantly reduce the risk of prolapse compared with vaginal delivery, according to a data presented at the joint International Continence Society—International Urogynecological Association annual meeting - but only if women had all their deliveries by Caesarian. Having even one baby vaginally removed this effect.

SAN FRANCISCO—Researchers have identified medical conditions that are independently associated with moderate to severe urinary incontinence (UI) in men. These include major depression, hypertension, and prostatic enlargement.

MONTREAL—A decade after contracting acute diarrheal illness from infection with Escherichia coli 0157:H7, individuals are at increased risk for definite renal impairment with microalbuminuria, hypertension, and cardiovascular events compared with individuals not infected with the pathogen.

MUNICH, GERMANY—Urinary tract infections (UTIs) caused by non-coliform bacteria are significantly more common among renal transplant patients compared with the general population, according to a British study.

They cause fewer UTIs than indwelling catheters in men at high risk during anesthesia and surgery.

The problems developed following 20% of major urologic procedures in patients with chronic bacteriuria.

In a study, only 3% of ESBL-producing Escherhicia coli isolates were resistant to fosfomycin.